Showing 1 - 20 results of 40 for search 'Westman, K', query time: 0.06s
Refine Results
-
1
-
2
Long-term follow up of EUVAS studies by Flossmann, O, Harper, L, Jayne, D, Luqmani, R, Westman, K
Published 2007Journal article -
3
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV) by Mukhtyar, C, Flomann, O, Brown, D, Westman, K, Jayne, D, Luqmani, R
Published 2008Conference item -
4
Cardiovascular outcomes in ANCA associated vasculitis by Mukhtyar, C, Flossmann, O, Brown, D, Westman, K, Jayne, D, Luqmani, R
Published 2008Conference item -
5
The prognostic value of BVAS and VDI in ANCA-AAV by Suppiah, R, Batra, R, Robson, J, Hoglund, P, Jayne, D, Westman, K, Luqmani, R
Published 2011Conference item -
6
-
7
Development of comprehensive disease assessment in systemic vasculitis. by Flossmann, O, Bacon, P, de Groot, K, Jayne, D, Rasmussen, N, Seo, P, Westman, K, Luqmani, R
Published 2007Journal article -
8
Development of comprehensive disease assessment in systemic vasculitis. by Flossmann, O, Bacon, P, de Groot, K, Jayne, D, Rasmussen, N, Seo, P, Westman, K, Luqmani, R
Published 2008Journal article -
9
-
10
-
11
Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides by Robson, J, Doll, H, Suppiah, R, Flossmann, O, Harper, L, Hoglund, P, Jayne, D, Mahr, A, Westman, K, Luqmani, R
Published 2013Conference item -
12
-
13
Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials. by Robson, J, Doll, H, Suppiah, R, Flossmann, O, Harper, L, Höglund, P, Jayne, D, Mahr, A, Westman, K, Luqmani, R
Published 2014Journal article -
14
-
15
FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS by Robson, J, Doll, H, Yew, S, Flossmann, O, Suppiah, R, Harper, L, Hoglund, P, Jayne, D, Mukhtyar, C, Westman, K, Luqmani, R
Published 2013Conference item -
16
-
17
-
18
Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS by Jones, R, Tervaert, J, Hauser, T, Luqmani, R, Peh, C, Savage, C, Segelmark, M, Tesar, V, Van Paassen, P, Walsh, M, Walsh, D, Westman, K, Jayne, D
Published 2009Journal article -
19
Long-term survival of ANCA-associated vasculitis by Flossmann, O, Berden, A, De Groot, K, Harper, L, Heijl, C, HOGlund, P, Jayne, D, Luqmani, R, Mahr, A, Mukhtyar, C, Pusey, C, Rasmussen, N, Westman, K
Published 2009Journal article -
20
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. by Jones, R, Tervaert, J, Hauser, T, Luqmani, R, Morgan, MD, Peh, C, Savage, C, Segelmark, M, Tesar, V, van Paassen, P, Walsh, D, Walsh, M, Westman, K, Jayne, DR
Published 2010Journal article